|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM359791670 |
| 003 |
DE-627 |
| 005 |
20240524232159.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202304249
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1417.xml
|
| 035 |
|
|
|a (DE-627)NLM359791670
|
| 035 |
|
|
|a (NLM)37478832
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Yan, Miaomiao
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Recent Progress of Supramolecular Chemotherapy Based on Host-Guest Interactions
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 24.05.2024
|
| 500 |
|
|
|a Date Revised 24.05.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2024 Wiley‐VCH GmbH.
|
| 520 |
|
|
|a Chemotherapy is widely recognized as an effective approach for treating cancer due to its ability to eliminate cancer cells using chemotherapeutic drugs. However, traditional chemotherapy suffers from various drawbacks, including limited solubility and stability of drugs, severe side effects, low bioavailability, drug resistance, and challenges in tracking treatment efficacy. These limitations greatly hinder its widespread clinical application. In contrast, supramolecular chemotherapy, which relies on host-guest interactions, presents a promising alternative by offering highly efficient and minimally toxic anticancer drug delivery. In this review, an overview of recent advancements in supramolecular chemotherapy based on host-guest interactions is provided. The significant role it plays in guiding cancer therapy is emphasized. Drawing on a wealth of cutting-edge research, herein, a timely and valuable resource for individuals interested in the field of supramolecular chemotherapy or cancer therapy, is presented. Furthermore, this review contributes to the progression of the field of supramolecular chemotherapy toward clinical application
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a cancer therapy
|
| 650 |
|
4 |
|a host–guest interactions
|
| 650 |
|
4 |
|a macrocycles
|
| 650 |
|
4 |
|a supramolecular chemistry
|
| 650 |
|
4 |
|a supramolecular chemotherapy
|
| 650 |
|
7 |
|a Antineoplastic Agents
|2 NLM
|
| 650 |
|
7 |
|a Drug Carriers
|2 NLM
|
| 700 |
1 |
|
|a Wu, Sha
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Yuhao
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Liang, Minghao
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Mengbin
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Hu, Wenting
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yu, Guocan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Mao, Zhengwei
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Huang, Feihe
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhou, Jiong
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 36(2024), 21 vom: 01. Mai, Seite e2304249
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:36
|g year:2024
|g number:21
|g day:01
|g month:05
|g pages:e2304249
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202304249
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 36
|j 2024
|e 21
|b 01
|c 05
|h e2304249
|